Intradermal influenza vaccination of healthy adults using a new microinjection system: A 3-year randomised controlled safety and immunogenicity trial

BMC Medicine

Volumn 7, Issue , 2009, Pages

  Beran, Jiri ^a   Ambrozaitis, Arvydas ^b   Laiskonis, Alvydas ^c   Mickuviene, Narseta ^c   Bacart, Patrick ^d,e   Calozet, Yvan ^d,e   Demanet, Etienne ^d,e   Heijmans, Stephane ^d,f   Van Belle, Paul ^d,g   Weber, Françoise ^h   Salamand, Camille ^h  

^a Vaccination and Travel Medicine Centre   (Czech Republic)

^b VILNIUS UNIVERSITY   (Lithuania)

^c KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^d ResearchLink   (Belgium)

^e A Clinical Trial Network of GPs ^*  (Belgium)

^f Private Practice   (Belgium)

^g Private Practice   (Belgium)

^h SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSE COMPARISON; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; ECCHYMOSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; MALAISE; MALE; MICROINJECTION; MULTICENTER STUDY; MYALGIA; NORMAL HUMAN; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SEROCONVERSION; SHIVERING; SIDE EFFECT; SWEATING; SYSTEMIC DISEASE; VIRUS STRAIN; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED;

ADULT; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; MALE; MICROINJECTIONS; MIDDLE AGED; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 65649089026     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-7-13     Document Type: Article

References (42)

1. Fleming DM Elliot AJ Lessons from 40 years' surveillance of influenza in England and Wales Epidemiol Infect 2007:1-10
2. Molinari NA Ortega-Sanchez IR Messonnier ML Thompson WW Wortley PM Weintraub E Bridges CB The annual impact of seasonal influenza in the US: Measuring disease burden and costs Vaccine 2007, 25:5086-5096 17544181
3. Fiore AE Shay DK Haber P Iskander JK Uyeki TM Mootrey G Bresee JS Cox NJ Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and prevention (CDC) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007 MMWR Recomm Rep 2007, 56:1-54 17625497
4. van Essen GA Palache AM Forleo E Fedson DS Influenza vaccination in 2000: Recommendations and vaccine use in 50 developed and rapidly developing countries Vaccine 2003, 21:1780-1785 12686094
5. Scuffham PA West PA Economic evaluation of strategies for the control and management of influenza in Europe Vaccine 2002, 20:2562-2578 12057614
6. Muller D Szucs TD Influenza vaccination coverage rates in 5 European countries: A population-based cross-sectional analysis of the seasons 02/ 03, 03/04 and 04/05 Infection 2007, 35:308-319 17885730
7. Glenn GM Kenney RT Ellingsworth LR Frech SA Hammond SA Zoeteweij JP Transcutaneous immunization and immunostimulant strategies: Capitalizing on the immunocompetence of the skin Expert Rev Vaccines 2003, 2:253-267 12899576
8. Glenn GM Kenney RT Mass vaccination: Solutions in the skin Curr Top Microbiol Immunol 2006, 304:247-268 16989274
9. Kissenpfennig A Malissen B Langerhans cells - revisiting the paradigm using genetically engineered mice Trends Immunol 2006, 27:132-139 16458606
10. Steinman RM The dendritic cell system and its role in immunogenicity Annu Rev Immunol 1991, 9:271-296 1910679
11. Nicolas JF Guy B Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice Expert Rev Vaccines 2008, 7:1201-1214 18844594
12. World Health Organization WHO Expert Consultation on rabies World Health Organ Tech Rep Ser 2005, 931:1-88 16485446
13. Vien NC Feroldi E Lang J Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children Trans R Soc Trop Med Hyg 2008, 102:294-296 18191971
14. Lang J Hoa DQ Gioi NV Vien NC Nguyen CV Rouyrre N Forrat R Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial Trans R Soc Trop Med Hyg 1999, 93:208-213 10450451
15. Egemen A Aksit S Kurugol Z Erensoy S Bilgic A Akilli M Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: A comparison of immunogenicity in infants and preschool children Vaccine 1998, 16:1511-1515 9711797
16. Chanchairujira T Chantaphakul N Thanwandee T Ong-Ajyooth L Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients J Med Assoc Thai 2006, 89(Suppl 2):S33-S40 17044452
17. Halsey NA Reppert EJ Margolis HS Francis DP Fields HA Intradermal hepatitis B vaccination in an abbreviated schedule Vaccine 1986, 4:228-232 3541426
18. Belshe RB Newman FK Wilkins K Graham IL Babusis E Ewell M Frey SE Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults Vaccine 2007, 25:6755-6763 2148502 17692438
19. Kenney RT Frech SA Muenz LR Villar CP Glenn GM Dose sparing with intradermal injection of influenza vaccine N Engl J Med 2004, 351:2295-2301 15525714
20. Belshe RB Newman FK Cannon J Duane C Treanor J Van Hoecke C Howe BJ Dubin G Serum antibody responses after intradermal vaccination against influenza N Engl J Med 2004, 351:2286-2294 15525713
21. Halperin W Weiss WI Altman R Diamond MA Black KJ Iaci AW Black HC Goldfield M A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/ 75: Report of a study and review of the literature Am J Public Health 1979, 69:1247-1251 1619316 507256
22. Laurent PE Bonnet S Alchas P Regolini P Mikszta JA Pettis R Harvey NG Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system Vaccine 2007, 25:8833-8842 18023942
23. Committee for Proprietary Medicinal Products (CPMP) Note for Guidance on Harmonisation of Requirements for Influenza Vaccines London: The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit 2008
24. Palmer DF Dowdle WR Coleman MT Shild GC Advanced laboratory technicals for immunological diagnostic Procedural Guide. Part 2. Haemagglutination - Inhibition Test Atlanta, GA: US Department of Health Education and Welfare 1975 Immunology Series No. 6
25. Newcombe RG Two-sided confidence intervals for the single proportion: comparison of seven methods Stat Med 1998, 17:857-872 9595616
26. Auewarakul P Kositanont U Sornsathapornkul P Tothong P Kanyok R Thongcharoen P Antibody responses after dose-sparing intradermal influenza vaccination Vaccine 2007, 25:659-663 17011678
27. Holland D Booy R Looze FD Eizenberg P McDonald J Karrasch J McKeirnan M Salem H Mills G Reid J Weber F Saville M Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial J Infect Dis 2008, 198:650-658 18652550
28. George A Shroff KE Rath S Ghosh SN Sengupta SR Kamat RS Route-related variation in the immunogenicity of killed Salmonella enteritidis vaccine: Role of antigen presenting cells Microbiol Immunol 1989, 33:479-488 2475750
29. Campton K Ding W Yan Z Ozawa H Seiffert K Miranda E Lonati A Beissert S Granstein RD Tumor antigen presentation by dermal antigen-presenting cells J Invest Dermatol 2000, 115:57-61 10886508
30. Fishbein DB Yenne KM Dreesen DW Teplis CF Mehta N Briggs DJ Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective study Vaccine 1993, 11:1390-1394 8310759
31. Thompson WW Shay DK Weintraub E Brammer L Bridges CB Cox NJ Fukuda K Influenza-associated hospitalizations in the United States JAMA 2004, 292:1333-1340 15367555
32. Prosser LA O'Brien MA Molinari NA Hohman KH Nichol KL Wortley PM Messonnier ML Lieu TA Cost-effectiveness of delivering adult influenza vaccination in non-traditional settings Pharmacoeconomics 2008, 26:163-178 18198935
33. Postma MJ Jansema P van Genugten ML Heijnen ML Jager JC Berg de Jong-van den LT Pharmacoeconomics of influenza vaccination for healthy working adults: Reviewing the available evidence Drugs 2002, 62:1013-1024 11985488
34. Langley JM Faughnan ME Prevention of influenza in the general population CMAJ 2004, 171:1213-1222 524953 15534315
35. World Health Organization Prevention and control of influenza pandemics and annual epidemics. WHA56.19, Agenda Item 14.14 Fifty-sixth World Health Assembly 2003
36. Orr P An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season Can Commun Dis Rep 2004, 30:1-32 15239483
37. Fiore AE Shay DK Broder K Iskander JK Uyeki TM Mootrey G Bresee JS Cox NS Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008 MMWR Recomm Rep 2008, 57:1-60 18685555
38. Blank PR Schwenkglenks M Szucs TD Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons BMC Public Health 2008, 8:272 2519082 18673545
39. Centers for Disease Control and Prevention (CDC) State-specific influenza vaccination coverage among adults aged > or = 18 years-United States, 2003-04 and 2005-06 influenza seasons MMWR Morb Mortal Wkly Rep 2007, 56:953-959 17882124
40. De Lataillade C Auvergne S Rivas N Delannoy I 2005 and 2006 seasonal influenza vaccination coverage rates and drivers in ten countries from Africa, Asia Pacific, Europe, Latin America and the Middle East Journal of Public Health Policy 2009 19367303
41. Johnson DR Nichol KL Lipczynski K Barriers to adult immunization Am J Med 2008, 121:S28-S35 18589065
42. Leroux-Roels I Vets E Freese R Seiberling M Weber F Salamand C Leroux-Roels G Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults Vaccine 2008, 26:6614-6619 18930093